REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.56
Bid: 4.30
Ask: 4.80
Change: 0.14 (3.17%)
Spread: 0.50 (11.628%)
Open: 4.16
High: 4.56
Low: 4.16
Prev. Close: 4.41
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brazil approves TEIKKOâ„¢

2 Jan 2024 07:00

RNS Number : 2675Y
Plant Health Care PLC
02 January 2024
 

2 January 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Brazil approves TEIKKO? (PHC68949) to Control Nematodes in Soybeans

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce that its nematicide, TEIKKO, has received federal approval in Brazil in time for commercial launch for the 2024/25 soybean growing season. 

 

Highlights

- TEIKKO is an entirely novel peptide product which offers farmers good control of nematode pests, without resorting to conventional agrochemicals;

- Brazilian farmers spent more than $200m on nematode control in the most recent season; and

- The Company is in discussion with potential distributors for launch of TEIKKO during 2024.

 

TEIKKO is a novel product, from the Company's PREtec peptide platform, that amplifies a plant's natural defense pathways to provide protection against plant parasitic nematodes which damage plant roots and limit crop yield. TEIKKO is now approved as a seed treatment for the control of root-lesion nematode (Pratylenchus brachyurus) in soybean. Research carried out during the 2021/22 and 2022/23 soybean crop seasons showed that TEIKKO gave similar or superior performance to standard agrochemical treatments. TEIKKO offers farmers the opportunity to avoid use of toxic agrochemicals, without sacrificing performance. Compared with alternative biological products, it brings benefits such as three-year shelf-life and no special requirements for storing, allowing flexibility on distribution to the farmers, low rates for easy industrial seed treatment, no interference or incompatibility with other traditional seed treatments, such as fungicides and insecticides, and reliable performance under different environmental conditions, such as drought or humidity. For the 2023/24 season, the soybean harvested area in Brazil is forecast to be 45 million hectares.

 

According to the latest research published by Kynetec, Brazilian growers spent $215 million on soybean nematode control for the 2022/23 season, which reflects an annualized growth rate of 55% over the last six years. Additional crops and nematode species will be added to the TEIKKO product label in the future, further expanding its potential use.

 

Plant Health Care is progressing discussions with several distribution partners who will launch TEIKKO in 2024, for use for the 2024/25 soybean growing season.

 

TEIKKO is based on the Company's innovative PREtec technology platform. Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates plant defense and pathogen resistance mechanisms within plants, resulting in improved crop growth and quality along with the ability to withstand a variety of abiotic stresses. 

 

Jeff Tweedy, CEO of Plant Health Care, said: ?TEIKKO will help Brazilian farmers sustainably produce their soybean crops and supports the Company's vision to be a leading global provider of alternatives to conventional agrochemicals. Unlike TEIKKO, current soil fumigants and other chemical nematicides are known to have damaging off-target effects. TEIKKO is an environmentally friendly biological alternative that performs as well as or better than those older technologies and we expect to see rapid adoption amongst Brazilian farmers. We are excited about the developing plans to launch TEIKKO in 2024, with strong growth thereafter."

 

# # #

 

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

Tel: +44 (0) 131 220 9771

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes, and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REATMBITMTIJBFJ
Date   Source Headline
11th Nov 20144:05 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement
29th Nov 201312:12 pmRNSDirector's Shareholding
25th Nov 20133:15 pmRNSDivestment of non-core subsidiary
18th Oct 20135:00 pmRNSTR-1 Notification of Major Interest in Shares
30th Sep 20135:00 pmRNSTotal Voting Rights
23rd Sep 201310:30 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSAppointment of Adviser
18th Sep 20133:15 pmRNSDirector/PDMR Shareholding
16th Sep 20137:03 amRNSDirectorate Change
16th Sep 20137:00 amRNSHalf Yearly Report
19th Aug 20132:30 pmRNSBlocklisting Interim Review
30th Jul 20137:01 amRNSUpdate on Harpin
30th Jul 20137:00 amRNSPHC announces plans for Harpin seed treatment
22nd Jul 201311:00 amRNSPHC hires Glen Donald as VP Business Development
19th Jul 20137:00 amRNSHead Office Relocation,Research Facility Expansion
15th Jul 20135:15 pmRNSDirector/PDMR Shareholding
5th Jul 20137:00 amRNSUpdate on CISX Listing
3rd Jul 20137:00 amRNSNew Long-Term Incentive Plan and Grant of Awards
7th Jun 20134:15 pmRNSDirectorate Change
31st May 201311:30 amRNSTotal Voting Rights
21st May 201312:00 pmRNSHarpin Granted Federal Registration in Mexico
10th May 20134:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.